Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

Next week, drugmakers will arrive at the JPMorgan Healthcare Conference in San Francisco feeling far more confident than in ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

The newly committed suite is the first of four manufacturing suites ProMed is constructing at Niagara Lane to support growing demand for manufacture of ophthalmic implants and other sustained-release ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his ...

From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time ...

Drug shortage relief targeted as PAI Pharma acquires Nivagen to expand domestic sterile injectable production in Sacramento, Calif.

Vicks accrued a total of 4.3 billion impressions on an estimated national TV ad spend of $18.9 million. The top network for ...